Raymond James Financial Services Advisors Inc. lessened its position in shares of Maximus, Inc. (NYSE:MMS – Get Rating) by 18.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 22,730 shares of the health services provider’s stock after selling 5,125 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Maximus were worth $1,315,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of the company. Avantax Advisory Services Inc. boosted its stake in Maximus by 5.2% during the second quarter. Avantax Advisory Services Inc. now owns 8,418 shares of the health services provider’s stock worth $526,000 after buying an additional 414 shares in the last quarter. Verition Fund Management LLC boosted its position in shares of Maximus by 128.3% during the 2nd quarter. Verition Fund Management LLC now owns 138,803 shares of the health services provider’s stock valued at $8,677,000 after acquiring an additional 78,012 shares in the last quarter. HGK Asset Management Inc. increased its stake in Maximus by 10.6% in the second quarter. HGK Asset Management Inc. now owns 10,500 shares of the health services provider’s stock valued at $656,000 after acquiring an additional 1,003 shares during the period. Zeke Capital Advisors LLC raised its position in Maximus by 48.2% in the second quarter. Zeke Capital Advisors LLC now owns 4,106 shares of the health services provider’s stock worth $257,000 after purchasing an additional 1,336 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in Maximus by 169.4% in the second quarter. Nordea Investment Management AB now owns 235,241 shares of the health services provider’s stock worth $14,458,000 after purchasing an additional 147,930 shares in the last quarter. Institutional investors and hedge funds own 97.41% of the company’s stock.
Maximus Price Performance
Shares of Maximus stock opened at $72.03 on Friday. Maximus, Inc. has a 1-year low of $54.46 and a 1-year high of $79.78. The firm’s 50-day moving average price is $70.73 and its two-hundred day moving average price is $64.47. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $4.38 billion, a price-to-earnings ratio of 21.89 and a beta of 0.70.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 28th. Investors of record on Wednesday, February 15th will be given a dividend of $0.28 per share. The ex-dividend date is Tuesday, February 14th. This represents a $1.12 annualized dividend and a yield of 1.55%. Maximus’s dividend payout ratio (DPR) is 34.04%.
Insiders Place Their Bets
In other Maximus news, General Counsel David Francis sold 1,800 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The shares were sold at an average price of $70.92, for a total value of $127,656.00. Following the completion of the transaction, the general counsel now directly owns 13,658 shares of the company’s stock, valued at $968,625.36. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, General Counsel David Francis sold 1,800 shares of the firm’s stock in a transaction that occurred on Wednesday, November 23rd. The shares were sold at an average price of $70.92, for a total value of $127,656.00. Following the completion of the sale, the general counsel now owns 13,658 shares of the company’s stock, valued at $968,625.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Raymond B. Ruddy acquired 5,730 shares of Maximus stock in a transaction on Wednesday, December 7th. The shares were purchased at an average cost of $69.91 per share, for a total transaction of $400,584.30. Following the acquisition, the director now owns 109,030 shares in the company, valued at approximately $7,622,287.30. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.
Analyst Ratings Changes
A number of research firms have weighed in on MMS. TheStreet raised Maximus from a “c+” rating to a “b-” rating in a report on Thursday, December 8th. StockNews.com initiated coverage on Maximus in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock.
Maximus Company Profile
MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.
- Get a free copy of the StockNews.com research report on Maximus (MMS)
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
- Microsoft Layoffs Signal Layoffs for Other Tech Companies?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.